• Instinct Bio completed its business combination with Relativity Acquisition Corp., positioning the regenerative medicine and longevity group to list on Nasdaq.
• Instinct Bio common stock and warrants are expected to start trading July 24, 2026 under the tickers BIOT and BIOTW.
• The deal implies a pro forma enterprise value of about $288 million at closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relativity Acquisition Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231615PRIMZONEFULLFEED9767271) on July 23, 2026, and is solely responsible for the information contained therein.